Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
11.06
-0.39 (-3.41%)
At close: Jun 10, 2026, 4:00 PM EDT
11.90
+0.84 (7.59%)
After-hours: Jun 10, 2026, 7:04 PM EDT
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $20.7 million as of June 10, 2026. Its market cap has increased by 357.10% in one year.
Market Cap
20.70M
Enterprise Value
8.43M
1-Year Change
357.10%
Ranking
Category
Stock Price
$11.06
Market Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $20.70M, an increase of 218.47%. That is a compound annual growth rate of 105.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 21.43M | 58.38% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 23.84M |
| Allarity Therapeutics | 23.04M |
| Celularity | 22.39M |
| VYNE Therapeutics | 21.95M |
| Vistagen Therapeutics | 21.20M |
| CervoMed | 20.83M |
| Pasithea Therapeutics | 19.39M |
| Traws Pharma | 18.94M |